Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults
Open Access
- 22 April 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (8)
Abstract
Background: SARS-CoV-2 infections are frequently milder in children than adults, suggesting that immune responses may vary with age. However, information is limited regarding SARS-CoV-2 immune responses in young children. Methods: We compared receptor binding domain–binding antibody (RBDAb) titers and SARS-CoV-2–neutralizing antibody titers, measured by pseudovirus-neutralizing antibody assay in serum specimens obtained from children aged 0–4 years and 5–17 years and in adults aged 18–62 years at the time of enrollment in a prospective longitudinal household study of SARS-CoV-2 infection. Results: Among 56 seropositive participants at enrollment, children aged 0–4 years had more than 10-fold higher RBDAb titers than adults (416 vs. 31, P < 0.0001) and the highest RBDAb titers in 11 of 12 households with seropositive children and adults. Children aged 0–4 years had only 2-fold higher neutralizing antibody than adults, resulting in higher binding-to-neutralizing antibody ratios compared with adults (2.36 vs. 0.35 for ID 50 , P = 0.0004). Conclusion: These findings suggest that young children mount robust antibody responses to SARS-CoV-2 following community infections. Additionally, these results support using neutralizing antibody to measure the immunogenicity of COVID-19 vaccines in children aged 0–4 years. Funding: CDC (award 75D30120C08737).Keywords
All Related Versions
Funding Information
- Centers for Disease Control and Prevention (75D30120C08737)
This publication has 20 references indexed in Scilit:
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protectionCell, 2021
- SARS-CoV-2 Transmission Dynamics in a Sleep-Away CampPediatrics, 2021
- Preexisting and de novo humoral immunity to SARS-CoV-2 in humansScience, 2020
- Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralizationJournal of Clinical Investigation, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicine, 2020
- Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patientsScience Translational Medicine, 2020
- COVID-19 in children: analysis of the first pandemic peak in EnglandArchives of Disease in Childhood, 2020
- Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- The role of anti‐flavivirus humoral immune response in protection and pathogenesisReviews in Medical Virology, 2020
- Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationImmunity, 2018